Medtronic gains FDA nod for artificial pancreas device

09/30/2013 | Star Tribune (Minneapolis-St. Paul, Minn.)

The FDA has granted Medtronic approval for what the company says is the first artificial pancreas device that stops insulin delivery automatically when the patient's blood sugar falls to preset levels. The MiniMed 530G with Enlite system, designed for diabetes patients 16 years or older, will be available commercially in the next few weeks.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA